Medical news
-
COVID-19 vaccination guidance for people with bleeding disorders
Guidance from the World Federation of Hemophilia (WFH), European Association for Haemophilia and Allied Disorders (EAHAD), European Haemophilia Consortium (EHC), and U.S. National Hemophilia Foundation...
-
Sanofi to resume dosing in fitusiran clinical studies with protocol amendments
Sanofi has announced plans to resume dosing in its ongoing fitusiran clinical studies, lifting the voluntary global hold that was initiated on October 30 to...
-
CSL Behring to discontinue plasma-derived therapy for hemophilia B
CSL Behring has announced the discontinuation of its plasma-derived factor IX concentrate Mononine®, used in the treatment and prevention of bleeding in hemophilia B, citing...
-
Global dosing hold in fitusiran trials initiated by Sanofi Genzyme to investigate new adverse events
A joint statement of the World Federation of Hemophilia (WFH), European Haemophilia Consortium (EHC) and National Hemophilia Foundation (NHF) November 6, 2020 – The WFH,...
-
Enrollment in gene therapy trials on hold for assessment of interim data: Takeda
Takeda has suspended screening and further enrollment in the clinical studies of its AAV8 gene therapies for the treatment of hemophilia A and B. The...
